The study drug is a potential new treatment for autoimmune disease.
Autoimmune diseases occur when a person’s immune system mistakenly attacks their own body, leading to inflammation and tissue damage in multiple organs.
According to the Australasian Society of Clinical Immunology and Allergy (ASCIA), autoimmune diseases are among the fastest growing chronic conditions in Australia. Autoimmune diseases
currently affect 5% of Australians.
This clinical trial has been approved by an independent ethics committee, and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!